 | Up a level |
Carbone, David Paul, Morgensztern, Daniel, Le Moulec, Sylvestre, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Dowlati, Afshin, Rudin, Charles M., Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Besse, Benjamin (2018). Efficacy and safety of rovalpituzumab tesirine in patients With DLL3-expressing, >= 3rd line small cell lung cancer: Results from the phase 2 TRINITY study. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Gautschi, Oliver, Wolf, Juergen, Milia, Julie, Filleron, Thomas, Carbone, David Paul, Camidge, D. Ross, Shih, Jin-Yuan, Awad, Mark M., Cabillic, Florian 
ORCID: 0000-0001-7204-5652, Peled, Nir, Van Den Heuvel, Michel, Owen, Dwight Hall, Kris, Mark G., Janne, Pasi A., Besse, Benjamin ORCID: 0000-0001-5090-8189, Cho, Byoung Chul, Karp, Daniel D., Rosell, Rafael, Mazieres, Julien and Drilon, Alexander E.
(2016).
Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755